Pavlina Konstantinova

Dr. Pavlina Konstantinova has eighteen years of experience in gene therapy. Dr. Konstantinova is a founder and Chief Scientific Officer of VectorY. Previously, she was a Vice President Research at uniQure, overseeing the development of multiple programs, and bringing the first AAV gene silencing platform in Huntington’s disease to the clinic.